edetic acid ๐Ÿถ Veterinary Use | Indications/Contra | FAERs-F | FAERs-M | Orange Bk | BioActivity |

Stem definitionDrug idCAS RN
987 60-00-4

Description:

MoleculeDescription

Molfile Inchi Smiles

Synonyms:

  • edetate disodium
  • edetic acid
  • EDTA
  • edathamil
  • endrate
  • ethylenedinitrilotetraacetic acid
  • edetate calcium disodium
  • calcium disodium versenate
A chelating agent that sequesters a variety of polyvalent cations such as CALCIUM. It is used in pharmaceutical manufacturing and as a food additive.
  • Molecular weight: 292.24
  • Formula: C10H16N2O8
  • CLOGP: -1.92
  • LIPINSKI: 0
  • HAC: 10
  • HDO: 4
  • TPSA: 155.68
  • ALOGS: -1.50
  • ROTB: 11

  • Status: OFP

  • Legend:
    OFP - off patent
    OFM - off market
    ONP - on patent

Drug dosage:

None

ADMET properties:

PropertyValueReference
BDDCS (Biopharmaceutical Drug Disposition Classification System) 3 Benet LZ, Broccatelli F, Oprea TI
S (Water solubility) 91 mg/mL Benet LZ, Broccatelli F, Oprea TI
EoM (Fraction excreted unchanged in urine) 95 % Benet LZ, Broccatelli F, Oprea TI
MRTD (Maximum Recommended Therapeutic Daily Dose) 66.03 ยตM/kg/day Contrera JF, Matthews EJ, Kruhlak NL, Benz RD

Approvals:

DateAgencyCompanyOrphan
July 16, 1953 FDA MEDICIS

FDA Adverse Event Reporting System (Female)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Gastrointestinal toxicity 387.06 99.62 81 2021 7660 63479260
Pulmonary toxicity 365.32 99.62 80 2022 9375 63477545
Neoplasm malignant 278.41 99.62 81 2021 29780 63457140
Joint injury 274.74 99.62 80 2022 29492 63457428
Hepatotoxicity 261.18 99.62 81 2021 36960 63449960
C-reactive protein abnormal 227.82 99.62 77 2025 46019 63440901
Joint stiffness 203.11 99.62 69 2033 41800 63445120
Therapy non-responder 200.81 99.62 80 2022 75821 63411099
Musculoskeletal pain 189.01 99.62 81 2021 92196 63394724
Musculoskeletal stiffness 135.78 99.62 81 2021 184537 63302383
Treatment failure 127.61 99.62 80 2022 198963 63287957
Therapeutic product effect incomplete 119.02 99.62 65 2037 124991 63361929
Infection 117.30 99.62 80 2022 229093 63257827

FDA Adverse Event Reporting System (Male)

None

FDA Adverse Event Reporting System (Geriatric)

MedDRA adverse event termLikelihood ratioLikelihood ratio thresholdPatients taking drug having adverse eventPatients taking drug not having adverse eventPatients not taking drug having adverse eventPatients not taking drug not having adverse event
Gastrointestinal toxicity 224.43 84.61 48 1600 8061 79734679
Pulmonary toxicity 202.19 84.61 48 1600 12866 79729874
Joint injury 160.01 84.61 48 1600 31287 79711453
Neoplasm malignant 159.30 84.61 48 1600 31762 79710978
Joint stiffness 143.44 84.61 47 1601 40783 79701957
Hepatotoxicity 136.70 84.61 48 1600 51304 79691436
C-reactive protein abnormal 124.09 84.61 44 1604 48323 79694417
Therapy non-responder 106.13 84.61 47 1601 92258 79650482
Musculoskeletal pain 104.62 84.61 48 1600 102306 79640434

FDA Adverse Event Reporting System (Pediatric)

None

Pharmacologic Action:

SourceCodeDescription
FDA PE N0000008556 Decreased Coagulation Factor Activity
FDA MoA N0000175089 Calcium Chelating Activity
CHEBI has role CHEBI:38161 Chelating agent
CHEBI has role CHEBI:50247 antidotes
CHEBI has role CHEBI:50249 anticoagulants
CHEBI has role CHEBI:166831 copper chelator
CHEBI has role CHEBI:176497 geroprotectors
MeSH PA D000925 Anticoagulants
MeSH PA D065096 Calcium Chelating Agents
MeSH PA D002614 Chelating Agents
MeSH PA D005503 Food Additives
MeSH PA D006401 Hematologic Agents
MeSH PA D064449 Sequestering Agents
FDA MoA N0000175962 Lead Chelating Activity
FDA EPC N0000175963 Lead Chelator
FDA EPC N0000175980 Anti-coagulant

Drug Use | Suggest Off label Use Form| |View source of the data|

DiseaseRelationSNOMED_IDDOID
Digitalis toxicity by EKG indication 6412007
Hypercalcemia indication 66931009 DOID:12678
Accidental poisoning by lead and its compounds and fumes indication 216777009
Cerebral edema contraindication 2032001
Anuria contraindication 2472002 DOID:2983
Hypocalcemia contraindication 5291005
Dehydration contraindication 34095006
Hypokalemia contraindication 43339004
Chronic heart failure contraindication 48447003
Acute nephropathy contraindication 58574008
Oliguria contraindication 83128009
Epilepsy contraindication 84757009 DOID:1826
Kidney disease contraindication 90708001 DOID:557
Inflammatory disease of liver contraindication 128241005
Pulmonary tuberculosis contraindication 154283005 DOID:2957
Disease of liver contraindication 235856003 DOID:409
Lesion of brain contraindication 301766008




๐Ÿถ Veterinary Drug Use

None

๐Ÿถ Veterinary products

None

Acid dissociation constants calculated using MoKa v3.0.0

Dissociation levelDissociation constantType (acidic/basic)
pKa1 0.96 acidic
pKa2 1.56 acidic
pKa3 2.15 acidic
pKa4 2.75 acidic
pKa5 10.12 Basic
pKa6 6.12 Basic

Orange Book patent data (new drug applications)

None

Orange Book exclusivity data (new drug applications)

Formulation strengthTrade nameApplicantApplication numberApproval dateTypeDose formRouteExclusivity dateDescription
200MG/ML EDETATE CALCIUM DISODIUM CASPER PHARMA LLC A216435 May 3, 2023 RX INJECTABLE INJECTION Jan. 8, 2024 COMPETITIVE GENERIC THERAPY

Bioactivity Summary:

TargetClassPharosUniProtActionTypeActivity value
(-log[M])
Mechanism
action
Bioact sourceMoA source
Angiotensin-converting enzyme Enzyme IC50 4.85 CHEMBL
Ceramide glucosyltransferase Enzyme WOMBAT-PK
Amyloid beta A4 protein Unclassified IC50 5.11 CHEMBL
Eyes absent homolog 2 Enzyme IC50 4.19 CHEMBL
Beta-lactamase Enzyme IC50 4.55 CHEMBL
Beta-lactamase VIM-1; Class B carbapenemase VIM-1; Metallo-beta-lactamase; Metallo-beta-lactamase VIM-1; Metallobeta-lactamase; VIM-1; VIM-1 metallo-beta lactamase; VIM-1 metallo-beta-lactamase; VIM-1 Unclassified IC50 5.03 CHEMBL
cAMP-specific 3',5'-cyclic phosphodiesterase 4B Enzyme IC50 4.13 CHEMBL

External reference:

IDSource
4031052 VUID
N0000183560 NUI
D00052 KEGG_DRUG
6381-92-6 SECONDARY_CAS_RN
6766-87-6 SECONDARY_CAS_RN
4017473 VANDF
4017479 VANDF
4017590 VANDF
4018923 VANDF
4031052 VANDF
C0013618 UMLSCUI
CHEBI:4735 CHEBI
EDT PDB_CHEM_ID
CHEMBL858 ChEMBL_ID
CHEMBL1749 ChEMBL_ID
CHEMBL3989507 ChEMBL_ID
DB00974 DRUGBANK_ID
CHEMBL3989522 ChEMBL_ID
D004492 MESH_DESCRIPTOR_UI
6049 PUBCHEM_CID
534 INN_ID
9G34HU7RV0 UNII
1903 RXNORM
23 MMSL
30988 MMSL
3413 MMSL
4651 MMSL
4652 MMSL
728 MMSL
NOCODE MMSL
d00742 MMSL
d01403 MMSL
001090 NDDF
001091 NDDF
002560 NDDF
003785 NDDF
387418006 SNOMEDCT_US
387428002 SNOMEDCT_US
69519002 SNOMEDCT_US
CHEMBL1200375 ChEMBL_ID

Pharmaceutical products:

ProductCategoryIngredientsNDCFormQuantityRouteMarketingLabel
Clinplant HUMAN OTC DRUG LABEL 1 47649-0002 GEL, DENTIFRICE 24 g DENTAL unapproved drug other 7 sections
Edetate Calcium Disodium Human Prescription Drug Label 1 64980-588 INJECTION 200 mg INTRAMUSCULAR ANDA 23 sections
Edetate Calcium Disodium Human Prescription Drug Label 1 70199-034 INJECTION 200 mg INTRAMUSCULAR ANDA 23 sections
YIGANERJING SuifurSoap HUMAN OTC DRUG LABEL 3 71939-003 SOAP 0.07 g TOPICAL unapproved drug other 7 sections
YIGANERJING SuifurSoap HUMAN OTC DRUG LABEL 3 71939-003 SOAP 0.07 g TOPICAL unapproved drug other 7 sections
MIIN FOOT HUMAN OTC DRUG LABEL 4 72988-0014 LIQUID 0.05 g TOPICAL OTC monograph not final 7 sections
Miracle FootCream Lavender HUMAN OTC DRUG LABEL 4 82145-0005 CREAM 0.05 g TOPICAL unapproved drug other 7 sections
Miracle FootCream Lemon HUMAN OTC DRUG LABEL 4 82145-0006 CREAM 0.05 g TOPICAL unapproved drug other 7 sections
Anubis Barcelona HUMAN OTC DRUG LABEL 12 83021-495 CONCENTRATE 0 g TOPICAL OTC monograph final 9 sections
Anubis Barcelona HUMAN OTC DRUG LABEL 12 83021-495 CONCENTRATE 0 g TOPICAL OTC monograph final 9 sections
Anubis Barcelona HUMAN OTC DRUG LABEL 13 83021-839 CONCENTRATE 0 g TOPICAL OTC monograph final 9 sections
Anubis Barcelona HUMAN OTC DRUG LABEL 13 83021-839 CONCENTRATE 0 g TOPICAL OTC monograph final 9 sections
Calcium Disodium Versenate HUMAN PRESCRIPTION DRUG LABEL 1 99207-240 INJECTION 200 mg INTRAMUSCULAR NDA 25 sections